Every six seconds in America, someone is diagnosed with type 2 diabetes. Every five seconds, another person starts a new prescription for it. Every day, 260 people die from it. Here’s what many Americans don’t know: type 2 diabetes is reversible. So is high blood pressure and many other chronic conditions, long treated as permanent. Not for everyone, but for millions, reversal is possible. Yet patients are rarely offered that option.
Now, 6 in 10 U.S. adults live with at least one chronic condition, and four in 10 live with two or more. These diseases account for 90 percent of our $4.5 trillion annual healthcare costs. They are the leading cause of death and disability, and they rob millions of Americans of energy, independence and quality of life. Yet, our healthcare system is not built to cure them. It’s designed to manage them indefinitely. Patients are kept on a treadmill of ongoing appointments, prescriptions and expensive tests that track decline rather than resolve it.
From day one, it’s about management
From the moment a patient is diagnosed, the conversation typically centers on management. Prescriptions are written, follow-up visits are scheduled and lab work is scheduled at regular intervals. Patients are taught how to keep their numbers “under control,” but they are rarely given a path to reverse the condition entirely. The message is clear: this is your new normal.
The language of management can feel reassuring at first. It offers structure, predictability and the sense that something is being done. But it also subtly tells the patient that this condition will be with them forever. The plan is about slowing progression and stabilization, not achieving resolution. That’s not because reversal is unrealistic. For many chronic diseases, reversal can be both possible and measurable. The problem is that our medical infrastructure rewards chronic treatment over recovery. And in many cases, clinicians themselves have little exposure to the tools that enable reversal.
Why we treat symptoms, not causes
Many chronic conditions are influenced by lifestyle and environment. They respond to targeted interventions in nutrition, physical activity, sleep quality, stress management and social support. In other words, they are influenced by daily habits and environmental factors that can be changed. Yet the system overwhelmingly focuses on symptom control rather than root causes.
Take type 2 diabetes. The standard goal is to lower blood sugar. Medications are prescribed to keep glucose levels in range, but little is done to restore the body’s ability to regulate blood sugar naturally. The same pattern holds for hypertension, where blood pressure medication is prescribed without addressing underlying factors such as diet, metabolic dysfunction or chronic stress. This is not neglect on the part of individual providers. It’s the result of a structure that is set up to maintain rather than to transform.
The fee-for-service model rewards ongoing treatment, not lasting outcomes. A patient who comes in every few months for lab work and medication adjustments is more valuable to the system financially than one who no longer needs those services. Medical education reinforces this by emphasizing pharmacology far more than nutrition, physical activity guidance or behavior change science. Pharmaceutical solutions fit neatly into this system because they are easy to standardize, prescribe and bill for. But control is not the same as cure, and decades of managing symptoms without improvement over time lead to patient disillusionment and resignation. A smarter path forward is value-based care, meaning a system that rewards doctors and health plans for helping patients get healthier; for reducing medications, not just renewing them. When outcomes are what drive reimbursement, reversal can become the goal rather than the exception. This is the kind of healthcare people deserve.
The belief gap
When patients aren’t told that reversal is possible, they stop asking if it can be done. This is the belief gap, and it might be the most powerful force keeping people trapped in long-term management. Once patients internalize that their condition is permanent, their choices narrow. They may take medications consistently, follow instructions carefully and still assume the best they can hope for is to avoid getting worse. Without the belief that change is possible, there is little reason to invest in the lifestyle shifts and sustained effort that reversal often requires. Closing this belief gap is not about false hope. It is about sharing evidence that change is possible and then providing a structured, realistic plan that makes change sustainable.
Reversal-centered care works
Reversal-focused care starts with a different premise: improvement is possible. It builds from that belief by equipping patients with the tools, guidance and accountability people need to succeed. Programs that combine evidence-based nutrition, personalized health plans and close monitoring of lab results can deliver dramatic changes. In many cases, patients reduce or even eliminate the need for medication, normalize key health markers and regain physical and mental vitality.
These results are not isolated miracles. Clinical research and real-world programs have shown they can be achieved at scale. At Ciba Health, patients have gone from injecting insulin daily to maintaining normal blood sugar. We have seen patients with high blood pressure return to healthy readings within months. We have seen people gain strength and experience mental clarity they had not felt in years. The common thread is that these patients were given the chance to work toward reversal instead of being told to settle for maintenance.
But if reversal works, why is it still the exception? Because shifting from management to cure requires changing the very incentives that drive healthcare. Providers and health systems would need to be rewarded for helping patients achieve remission and stay healthy, not for the volume of appointments or prescriptions. Lifestyle medicine would need to be a core part of primary care instead of an optional extra.
Employers and insurers would need to recognize the significant cost savings that come from healthier populations and actively invest in programs that deliver those results.
The stakes are enormous. Chronic conditions cost the U.S. trillions of dollars each year, but the real cost is in years of life lost, diminished quality of life and communities burdened by preventable illness. The return on reversing these conditions is not just financial, but the restoration of human potential.
Medication will always play a role in treatment, especially in the early stages of chronic disease. But it should be a bridge to better health, not the final stop. Success should be measured by how many people no longer need medication, not by how well we manage to keep them dependent on it without further decline. This shift in measurement alone would fundamentally change how healthcare approaches treatment.
From maintenance to transformation
We don’t have to accept chronic illness as a life sentence, but doing better requires redefining healthcare itself. Managing symptoms is predictable and profitable, and curing conditions is disruptive. Yet disruption is exactly what we need.
The science exists. The proof exists. Patients are ready. What is missing is the institutional will to reimagine the system so that cure is not the exception but the expectation. Until we do, we will continue to spend more, treat more and cure less. The future of healthcare will be determined by whether we choose to maintain the status quo of managing decline, or choose, finally, to reverse it.
Want more insights? Join Working Title - our career elevating newsletter and get the future of work delivered weekly.
